Accera Completes $35 Million Series C Financing

Accera announced it has recently closed a Series C financing round of $35 million (euro 27 million), led by Inventages Venture Capital SA. The company says that the proceeds of this financing will be used to begin sales and marketing ofthe company’s lead product, Axona(TM) (previously known as Ketasyn), which as the company says, is [...]

Neuroptix Raises $18.5 Million in Successful B Round

Neuroptix Corporation has successfully raised a total of $18.5 million in its Series B funding round, as the company advances its diagnostic Alzheimer’s test toward clinical trials.
The investment, led by Inventages, will advance continued development of the Neuroptix Sapphire diagnostic platform and related technologies. The Neuroptix Sapphire system consists of a non-contact optical device combined [...]

Apitope Raises EUR 10 Million in Series A Financing

Apitope International, the developer of novel peptide-based therapies for autoimmune diseases and allergies, announced the closing of a EUR 10 million series A financing. The funds will be used to further develop ATXMS- 1467, which is due to enter Phase II trials next year to treat Multiple Sclerosis (MS). Apitope is also developing a MS [...]

Proteostasis Rakes in $45M in Series A

Image via Wikipedia
Um. Wow. $45M?
Proteostasis announced that it has secured $45 million in a Series A financing to develop drugs as novel therapies to treat multiple genetic and degenerative disorders associated with protein homeostasis deficiencies. Investors included HealthCare Ventures, Fidelity Biosciences, New Enterprise Associates, Novartis Option Fund and Genzyme Ventures.
On paper, this company smells [...]

Heathcare / Medical Venture Capital Groups

I’ve compiled a list of relevant healthcare / biotech / med device / pharma VC groups.
Enjoy.

Weekly Biopharm Financing: Cardiome, Genomic Vision, RF Surgical, NuPathe, Cell and Cara Tharapeutics

NuPathe (Business Wire)
Raised $30 million in a Series B, private stock sale. They will mainly use the funds to support the phase 3 trial of their sumatriptan patch for migraine but some money will get funneled into their Parkinson’s
Cardiome (PRNewswire)
Under the non-brokered private placement, Cardiome has entered into an agreement to sell 2,272,727 Series [...]

Novartis Buys Protez For Superbug Defense

Image via Wikipedia

Novartis AG strengthened its specialty medicines development portfolio by buying the private, Protez Pharmaceuticals, today for $100M upfront and the potential for up to $400M dependent on meeting certain developmental milestones.
PZ-601, the lead compound, is a broad-spectrum beta-lactam, for the potential treatment of bacterial infections including complicated skin and skin structure infections (cSSSI) [...]

Funding Roundup: IRX, Genesis, Inimex, VeraLight and ONCODESIGN

Busy day on the funding side today. Too many to keep up with and I’m pretty sure I missed a couple but, no time for whining:

ONCODESIGN Secures 4.7M in Financing
VeraLight secures $20 million series C financing for a non-invasive diabetes screening system
IRX therapeutics completes $25 million series A preferred stock offering to continue clinical development [...]

Financing for Concert Pharmaceuticals

CoNCERT Pharmaceuticals, Inc. Raises $37 Million in Series C Financing
CoNCERT Pharmaceuticals, Inc., announced the closing of a $37 million Series C financing today. The Company intends to use the proceeds to further advance its deuterium chemistry platform and product pipeline. The financing was led by a leading public equity institutional investor and included participation [...]